Belvedere Trading »

Tempest Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Tempest Therapeutics (TPST) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Tempest Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tempest Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tempest Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $312k 30k 10.28
2025-06-30 $13k 24k 0.53

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Strategy Cl A New (MSTR)
Apple (AAPL)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Palantir Technologies Cl A (PLTR)

View all positions for Belvedere Trading

Top funds holding Tempest Therapeutics

Vanguard Group
Geode Capital Management
BlackRock
FMR
Belvedere Trading
DRW Holdings
UBS Group
Morgan Stanley
Advisor Group Holdings
Atlantic Trust
Federation des caisses Desjardins du Quebec
SBI Securities
Parallel Advisors
Wells Fargo & Company
Bnp Paribas Arbitrage, Snc

View all funds holding Tempest Therapeutics